These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 11016919)

  • 1. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling.
    Lin X; Liang M; Feng XH
    J Biol Chem; 2000 Nov; 275(47):36818-22. PubMed ID: 11016919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation.
    Bonni S; Wang HR; Causing CG; Kavsak P; Stroschein SL; Luo K; Wrana JL
    Nat Cell Biol; 2001 Jun; 3(6):587-95. PubMed ID: 11389444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
    Xu J; Attisano L
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase.
    Zhang Y; Chang C; Gehling DJ; Hemmati-Brivanlou A; Derynck R
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):974-9. PubMed ID: 11158580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.
    Kavsak P; Rasmussen RK; Causing CG; Bonni S; Zhu H; Thomsen GH; Wrana JL
    Mol Cell; 2000 Dec; 6(6):1365-75. PubMed ID: 11163210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins.
    Fukuchi M; Imamura T; Chiba T; Ebisawa T; Kawabata M; Tanaka K; Miyazono K
    Mol Biol Cell; 2001 May; 12(5):1431-43. PubMed ID: 11359933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins.
    Nakano A; Koinuma D; Miyazawa K; Uchida T; Saitoh M; Kawabata M; Hanai J; Akiyama H; Abe M; Miyazono K; Matsumoto T; Imamura T
    J Biol Chem; 2009 Mar; 284(10):6109-15. PubMed ID: 19122240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-dependent degradation of TGF-beta-activated smad2.
    Lo RS; Massagué J
    Nat Cell Biol; 1999 Dec; 1(8):472-8. PubMed ID: 10587642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Smad pathway.
    Wrana JL; Attisano L
    Cytokine Growth Factor Rev; 2000; 11(1-2):5-13. PubMed ID: 10708948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
    Zhu H; Kavsak P; Abdollah S; Wrana JL; Thomsen GH
    Nature; 1999 Aug; 400(6745):687-93. PubMed ID: 10458166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrophin-1-interacting protein 4/human Itch is a ubiquitin E3 ligase for human enhancer of filamentation 1 in transforming growth factor-beta signaling pathways.
    Feng L; Guedes S; Wang T
    J Biol Chem; 2004 Jul; 279(28):29681-90. PubMed ID: 15051726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation.
    Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A
    EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signaling.
    Inoue Y; Kitagawa M; Onozaki K; Hayashi H
    J Interferon Cytokine Res; 2004 Jan; 24(1):43-54. PubMed ID: 14980084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis.
    Togawa A; Yamamoto T; Suzuki H; Fukasawa H; Ohashi N; Fujigaki Y; Kitagawa K; Hattori T; Kitagawa M; Hishida A
    Am J Pathol; 2003 Oct; 163(4):1645-52. PubMed ID: 14507671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Fukai Y; Masuda N; Miyazaki T; Nakajima M; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
    Cancer Res; 2002 Dec; 62(24):7162-5. PubMed ID: 12499250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMURF2 and SMAD7 induce SARA degradation via the proteasome.
    Wojtowicz S; Lee S; Chan E; Ng E; Campbell CI; Di Guglielmo GM
    Cell Signal; 2020 Aug; 72():109627. PubMed ID: 32283253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional induction of Smurf2 ubiquitin ligase by TGF-beta.
    Ohashi N; Yamamoto T; Uchida C; Togawa A; Fukasawa H; Fujigaki Y; Suzuki S; Kitagawa K; Hattori T; Oda T; Hayashi H; Hishida A; Kitagawa M
    FEBS Lett; 2005 May; 579(12):2557-63. PubMed ID: 15862290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.